Clinical Trials Directory

Trials / Completed

CompletedNCT00315926

Melatonin and Cardiac Outcome After Major Surgery

Melatonin and Cardiac Morbidity After Elective Abdominal Aortic Aneurism Repair

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
52 (actual)
Sponsor
University Hospital, Gentofte, Copenhagen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess whether treatment with melatonin can reduce cell damage and inflammatory stress response and thereby occurrence of myocardial injury after abdominal aortic surgery.

Detailed description

Abdominal aortic surgery is associated with a significant increase of oxidative and inflammatory stress response. Aortic surgery is also associated with elevated troponin which is a sensitive and specific marker for myocardial injury. The severity of oxidative stress is correlated with elevated troponin. Melatonin, which is a hormone produced in brain, seems to modify cell damage and inflammation. On the other hand we know, that melatonin production first night after surgery is disturbed. The purpose of this study is therefore to determine whether treatment with melatonin can reduce cell damage and inflammation, and thereby occurrence of myocardial injury associated with abdominal aortic surgery.

Conditions

Interventions

TypeNameDescription
DRUGMelatoninMelatonin 50 mg during surgery and 10 mg every night for 3 nights
DRUGPlaceboa mixture of ethanol and physiological saline

Timeline

Start date
2007-01-01
Primary completion
2008-07-01
Completion
2008-07-01
First posted
2006-04-19
Last updated
2010-06-30

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00315926. Inclusion in this directory is not an endorsement.